VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NXTC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NXTCNextCure, Inc.
$2.07$6M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNXTCQuarterly Financials

NextCure, Inc. (NXTC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

NextCure, Inc. (NXTC) quarterly income statement — complete revenue, gross profit & net income history

NXTC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold283K000000701K000000000000
COGS % of Revenue--------------------
Gross Profit-283K000000-701K000000000000
Gross Margin %--------------------
Gross Profit Growth %---100%----------------
Operating Expenses9.82M9.76M8.95M27.29M11.62M12.46M12.49M15.79M18.3M15.79M15.62M19.16M17.07M17.77M19.24M18.13M20.77M17.07M18.51M17.95M
OpEx % of Revenue--------------------
Selling, General & Admin3.27M2.96M2.81M3.2M3.73M3.55M3.73M3.38M4.36M3.96M4.61M5.71M5.42M4.95M5.71M5.3M5.75M4.81M4.91M6.01M
SG&A % of Revenue--------------------
Research & Development6.83M6.8M6.14M24.09M7.9M8.9M8.77M12.42M11.4M11.83M11.01M13.45M11.65M12.82M13.53M12.82M15.02M12.26M13.6M11.95M
R&D % of Revenue--------------------
Other Operating Expenses-283K00000001000K00000000000
Operating Income-10.11M-9.76M-8.95M-27.29M-11.62M-12.46M-12.49M-16.49M-18.3M-15.79M-15.62M-19.16M-17.07M-17.77M-19.24M-18.13M-20.77M-17.07M-18.51M-17.95M
Operating Margin %--------------------
Operating Income Growth %13.05%21.66%28.41%-65.47%36.51%21.12%20%13.91%-7.22%11.15%18.82%-5.68%17.81%-4.1%-3.95%-0.98%-20.52%-5.14%-6.37%-13.61%
EBITDA-9.82M-9.39M-8.41M-26.66M-10.97M-11.78M-11.79M-15.79M-17.51M-14.97M-14.67M-18.2M-16.11M-16.76M-18.22M-17.09M-19.71M-14.97M-16.77M-17.66M
EBITDA Margin %--------------------
EBITDA Growth %10.45%20.28%28.68%-68.8%37.38%21.28%19.61%13.24%-8.71%10.73%19.46%-6.52%18.27%-12%-8.66%3.24%-22.22%1.83%-1.53%-17.64%
D&A (Non-Cash Add-back)283K365K533K633K654K674K700K701K790K824K946K954K960K1.01M1.02M1.04M1.06M2.1M1.74M289K
EBIT-10.11M-9.76M-8.62M-27.29M-11.62M-12.46M-12.49M-16.49M-15.76M-15.79M-15.62M-19.16M-17.07M-17.77M-19.24M-18.13M-20.77M-17.07M-18.51M-17.95M
Net Interest Income00000000000000000000
Interest Income00000000000000000000
Interest Expense00000000000000000000
Other Income/Expense309K321K321K484K646K852K955K1.09M1.2M1.32M1.32M1.3M975K471K328K208K169K132K578K-35K
Pretax Income-9.8M-9.44M-8.62M-26.81M-10.98M-11.6M-11.54M-15.4M-17.11M-14.47M-14.3M-17.86M-16.1M-17.3M-18.91M-17.92M-20.6M-16.94M-17.93M-17.99M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-9.8M-9.44M-8.62M-26.81M-10.98M-11.6M-11.54M-15.4M-17.11M-14.47M-14.3M-17.86M-16.1M-17.3M-18.91M-17.92M-20.6M-16.94M-17.93M-17.99M
Net Margin %--------------------
Net Income Growth %10.75%18.68%25.27%-74.03%35.84%19.8%19.31%13.75%-6.28%16.38%24.38%0.34%21.87%-2.13%-5.47%0.37%-24.61%-9.56%-9.55%-23.98%
Net Income (Continuing)-9.8M-9.44M-8.62M-26.81M-10.98M-11.6M-11.54M-15.4M-17.11M-14.47M-14.3M-17.86M-16.1M-17.3M-18.91M-17.92M-20.6M-16.94M-17.93M-17.99M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.87-2.69-3.22-11.29-4.70-4.97-4.95-6.61-7.36-6.22-6.16-7.70-6.95-7.47-8.18-7.75-8.92-7.35-7.79-7.82
EPS Growth %60.24%45.89%34.95%-70.85%36.08%20.07%19.7%14.19%-5.79%16.78%24.62%0.64%22.06%-1.64%-4.96%0.85%-24.11%-9.27%-9.28%-23.57%
EPS (Basic)-1.87-2.69-3.22-11.29-4.70-4.97-4.95-6.61-7.36-6.22-6.16-7.70-6.95-7.47-8.18-7.75-8.92-7.35-7.79-7.82
Diluted Shares Outstanding5.24M3.51M2.68M2.37M2.33M2.33M2.33M2.33M2.33M2.33M2.32M2.32M2.31M2.31M2.31M2.31M2.31M2.3M2.3M2.3M
Basic Shares Outstanding5.24M3.51M2.68M2.37M2.33M2.33M2.33M2.33M2.33M2.33M2.32M2.32M2.31M2.31M2.31M2.31M2.31M2.3M2.3M2.3M
Dividend Payout Ratio--------------------